Evidence map›Paper›PMID 30917981›Full record

ArticleAntimicrobial agents and chemotherapy2019

Population Pharmacokinetics with Monte Carlo Simulations of Gentamicin in a Population of Severely Ill Adult Patients from Sub-Saharan Africa.

Jeannet C Bos, Jan M Prins, Mabor C Mistício, Ginto Nunguiane, Cláudia N Lang, José C Beirão, Ron A A Mathôt, Reinier M van Hest

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jeannet C BosAmsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam, the Netherlands j.c.bos@amc.nl.
Jan M PrinsAmsterdam UMC, University of Amsterdam, Department of Internal Medicine, Division of Infectious Diseases, Amsterdam, the Netherlands.
Mabor C MistícioCatholic University of Mozambique (UCM), Research Center for Infectious Diseases of the Faculty of Health Sciences (CIDI), Beira, Mozambique.
Ginto NunguianeCatholic University of Mozambique (UCM), Research Center for Infectious Diseases of the Faculty of Health Sciences (CIDI), Beira, Mozambique.
Cláudia N LangCatholic University of Mozambique (UCM), Research Center for Infectious Diseases of the Faculty of Health Sciences (CIDI), Beira, Mozambique.
José C BeirãoCatholic University of Mozambique (UCM), Research Center for Infectious Diseases of the Faculty of Health Sciences (CIDI), Beira, Mozambique.
Ron A A MathôtAmsterdam UMC, University of Amsterdam, Department of Hospital Pharmacy, Division of Clinical Pharmacology, Amsterdam, the Netherlands.
Reinier M van HestAmsterdam UMC, University of Amsterdam, Department of Hospital Pharmacy, Division of Clinical Pharmacology, Amsterdam, the Netherlands.
Catholic University of Mozambique · MZUniversity of Amsterdam · NLAmsterdam University Medical Centers · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In sub-Saharan Africa (SSA), gentamicin is commonly used for severe infections in non-intensive-care-unit (ICU) settings, but pharmacokinetic and pharmacodynamic data for this specific population are lacking. We performed a population pharmacokinetic study in an adult Mozambican non-ICU hospital population treated with gentamicin (

Indexed as

AdultAfrica South of the SaharaAgedAged, 80 and overAnti-Bacterial AgentsCritical IllnessFemaleGentamicinsHumansIntensive Care UnitsMaleMicrobial Sensitivity TestsMiddle AgedModels, BiologicalMonte Carlo MethodYoung AdultAnti-Bacterial AgentsGentamicinsaminoglycosidesgentamicinpharmacodynamicspopulation pharmacokineticssevere illnesssub-Saharan Africa

Identifiers

PMID30917981
PMCPMC6437512
OpenAlexW2924328176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.